Skip to content

Observational Study of Blood Pressure Measurements and Continuous Dialysis

Observational Study Evaluating the Hemodynamic Relationship Between Volume Removal and Pulse Pressure Variation During Renal Replacement Therapy

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01286506
Enrollment
7
Registered
2011-01-31
Start date
2011-02-28
Completion date
2015-12-31
Last updated
2016-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Kidney Failure, Respiratory Failure, Shock

Keywords

Pulse pressure variation, Continuous venovenous hemodialysis, Volume status, Critical care

Brief summary

Dialysis is used to control the fluid balance and metabolic state of patients with kidney disease. Control of the metabolic state, via electrolytes, can be monitored using labs that are routinely drawn from patients undergoing continuous hemodialysis. Control of fluid removal is much more difficult. This study aims to determine whether changes in the blood pressure associated with breathing correlate with or predict intolerance to fluid responsiveness with continuous dialysis. We hypothesize that a measurement of changes in blood pressure with breathing called arterial pulse pressure variation may be able to predict the ability to remove fluid during continuous renal replacement therapy.

Interventions

None listed

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 17 years old * CVVHD renal replacement therapy * indwelling arterial line

Exclusion criteria

* age \< 18 years old * pregnancy * temperature \< 34°C * severe mechanical ventilator dyssynchrony * cardiac arrhythmias precluding automated PPV measurement by ICU monitors * non-pulsatile cardiac flow * open thoracic cavity

Design outcomes

Primary

MeasureTime frame
Predictive value of pulse pressure variation for tolerance of fluid removal on CVVHDIterative 24 hr periods for the duration of CRRT

Secondary

MeasureTime frame
Increased doses of vasoactive agents on CRRTIterative 24 hr periods for the duration of CRRT
Inability to meet goal ultrafiltration rateIterative 24 hr periods for the duration of CRRT
Hypotensive events on CRRTIterative 24 hr periods for the duration of CRRT

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026